Table 2. Baseline Mediterranean diet score related to 3-year incidence of abnormalities in each component of metabolic syndrome in the study population ^a.

Mediterranean diet scores
Diet Score	Total	T1			T2			T3			P-trend
		n (%) b	OR	95%CI	n (%) b	OR	95%CI	n (%) b	OR	95%CI
MDS
High WCc	1123	103 (30)	1.00	ref	87 (28.8)	0.86	0.54, 1.38	147 (30.8)	0.74	0.48, 1.13	0.56
High FPGd	2045	74 (13.7)	1.00	ref	82 (15.5)	1.01	0.77, 1.57	171 (17.5)	1.01	0.73, 1.39	0.55
High TGe	1530	63 (14.4)	1.00	ref	48 (12.3)	0.74	0.48, 1.12	110 (15.7)	0.81	0.56, 1.17	0.43
Low HDLf	817	32 (14.3)	1.00	ref	25 (12.6)	0.99	0.55, 1.78	39 (9.9)	0.82	0.48, 1.40	0.22
High BPg	1837	85(17.0)	1.00	ref	65 (13.6)	0.70	0.48,1.02	170 (19.8)	0.89	0.64, 1.22	0.95
Sofi-MDS
High WC	1123	128(26.9)	1.00	ref	108 (29.3)	1.07	0.71, 1.62	101 (36.1)	0.84	0.52, 1.33	0.82
High FPG	2045	125 (15.1)	1.00	ref	102 (14.2)	0.82	0.61, 1.10	100 (20.0)	1.23	0.89, 1.70	0.40
High TG	1530	89 (14.2)	1.00	ref	84 (15.8)	0.95	0.67, 1.34	48 (13.0)	0.77	0.51, 1.17	0.79
Low HDL	817	34 (10.0)	1.00	ref	37 (12.8)	1.15	0.68, 1.96	25 (13.2)	1.09	0.60, 1.99	0.16
High BP	1837	126 (16.7)	1.00	ref	121 (19.1)	10.06	0.77, 1.45	73 (16.2)	0.82	0.56, 1.20	0.17

^a Adjusted for age, sex, energy Intake, physical activity, smoking, BMI baseline and BMI Change in 3 years follow-up. Abbreviations: WC, waist circumference; FPG, fasting plasma glucose; TG, Triglycerides; HDL-C, HDL cholesterol; BP, blood pressure; ref, referent category.

^b Number of new cases for each component by tertiles.

^c WC ≥ 90 cm for both sexes.

^d FPG ≥ 5.6 mmol/L or drug treatment for elevated glucose.

^e TG ≥ 1.7 mmol/L or drug treatment for high triglycerides.

^f HDL-C (< 1.0 mmol/L in men or < 1.3 mmol/L) in women or drug treatment.

^g Systolic ≥ 130 and/or diastolic ≥ 85 mmHg or antihypertensive drug treatment.